EXOSOME NANOCARRIERS: BASIC BIOLOGY, DIAGNOSIS, NOVEL AND PERSPECTIVE APPROACH IN DRUG DELIVERY SYSTEMS: A REVIEW
Keywords:Drug delivery, Exosomes, Functional therapeutics, Nanotechnology
Exosomes are the extracellular vesicles surrounded by a phospholipid bilayer shed from all cell varieties and plays a significant role in the communication and Transportation of materials between the cells due to their ability to transfer the proteins and nucleic acids from One cell to the another cell. Analogous in size and performance to synthetic nanoparticles, exosomes provide several Advantages, rendering them the foremost promising candidates for targeted drug or gene delivery vehicles. This review highlights the isolation techniques and delivery potential of exosomes, and equally presents research or analysis gaps for enhancing the use of natural vesicles for delivery functions. Exosome-based drug formulations can be applied to an extensive variety of diseases such as various infectious, cardiovascular, cancer and neurodegenerative disorders. Mostly, exosomes combine the benefits of both synthetic nanocarriers and cell-mediated drug delivery systems however avoiding their limitations.
Boorn JGV, Daßler J, Coch C, Schlee M, Hartmann G. Exosomes as nucleic acid nanocarriers. Adv Drug Delivery Rev 2013;65:331-5.
Raposo G, Nijman HW, Stoorvogel W. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183:1161-72.
Record M, Carayon K, Poirot M, Silvente Poirot S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophysica Acta Molecular Cell Biol Lipids 2014;1841:108-20.
Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neuro-Oncol 2013;113:1-11.
Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011;12:1659-68.
Skokos D, Botros HG, Demeure C. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol 2003;170:3037-45.
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
Huotari J, Helenius A. Endosome maturation. EMBO J 2011;30:3481-500.
Hanson PI, Cashikar A. Multivesicular body morphogenesis. Annual Rev Cell Dev Biol 2012;28:337-62.
Palma J, Yaddanapudi SC, Pigati L. MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res 2012;40:9125-38.
Penfornis P, Vallabhaneni KC, Whitt J, Pochampally R. Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment. Int J Cancer 2016;138:14-21.
Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics 2017;7:789.
Chiou NT, Ansel KM. Improved exosome isolation by sucrose gradient fractionation of ultracentrifuged crude exosome pellets. Protocol Exchange 2016;10:57.
Munagala R, Aqil F, Jeyabalan J, Gupta RC. Bovine milk-derived exosomes for drug delivery. Cancer Lett 2016;371:48-61.
Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev 2016;8:409-27.
Bob Carr, Matthew Wright. Nanoparticle tracking analysis, a review of applications and Usage; 2010-12.
Hou W, Cronin SB. A review of surface plasmon resonance-enhanced photocatalysis. Adv Functional Materials 2012;23:1612-9.
Lobb RJ, Becker M, Wen SW. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracellular Vesicles 2015;4:27031.
Andaloussi SE, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat Rev Drug Discovery 2013;12:347-57.
Hood RR, Vreeland WN, DeVoe DL. Microfluidic remote loading for rapid single-step liposomal drug preparation. Lab Chip 2014;14:3359-67.
Pascucci L, Coccè V, Bonomi A. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery. J Controlled Release 2014;192:262-70.
Lee J, Kim J, Jeong M. Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration. Nano Lett 2015;15:2938-44.
Lee J, Lee H, Goh U. Cellular engineering with membrane fusogenic liposomes to produce functionalized extracellular vesicles. ACS Appl Materials Interfaces 2016;8:6790-5.
Akao Y, Nakagawa Y, Hirata I. Role of anti-oncomirs miR-143 and-145 in human colorectal tumors. Cancer Gene Ther 2010;17:398-408.
Ohno S, Takanashi M, Sudo K. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 2013;21:185-91.
Sun D, Zhuang X, Xiang X. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 2010;18:1606-14.
Didiot MC, Hall LM, Coles AH. Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol Ther 2016;24:1836-47.
Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Controlled Release 2015;205:35-44.
Haney MJ, Klyachko NL, Zhao Y. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Controlled Release 2015;207:18-30.
Kooijmans SAA, Stremersch S, Braeckmans K. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Controlled Release 2013;172:229-38.
Kim MS, Haney MJ, Zhao Y. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed: Nanotechnol Biol Med 2016;12:655-64.
Lamichhane TN, Jeyaram A, Patel DB. Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication. Cellular Molecular Bioengineering 2016;9:315-24.
Sato YT, Umezaki K, Sawada S. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 2016;6:21933.
Podolak I, Galanty A, Sobolewska D. Saponins as cytotoxic agents: a review. Phytochem Rev 2010;9:425-74.
Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009;6:267-83.
Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Molecular Cellular Proteomics 2006;5:1760-71.
Dai S, Zhou X, Wang B. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8+CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. J Mol Med 2006;84:1067-76.
Liu C, Yu S, Zinn K. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006;176:1375-85.
Salido Guadarrama I, Romero Cordoba S, Peralta Zaragoza O, Hidalgo Miranda A, Rodriguez Dorantes M. MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. OncoTargets Ther 2014;7:1327.
Mahaweni NM, Kaijen Lambers ME, Dekkers J, Aerts JG, Hegmans JP. Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma. J Extracellular Vesicles 2013;2:22492.
Chaudhuri AA, So AY, Sinha N. MicroRNA-125b potentiates macrophage activation. J Immunol 2011;187:5062-8.
Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active wnt proteins are secreted on exosomes. Nat Cell Biol 2012;14:1036-45.
Lai RC, Yeo RW, Tan KH, Lim SK. Exosomes for drug delivery-a novel application for the mesenchymal stem cell. Biotechnol Adv 2013;31:543-51.
Chaput N. Dendritic cell derived-exosomes: biology and clinical implementations. J Leukocyte Biol 2006;80:471-8.
Basu J, Ludlow JW. Exosomes for repair, regeneration and rejuvenation. Expert Opinion Biol Ther 2016;16:489-506.
Russo I, Bubacco L, Greggio E. Exosomes-associated neurodegeneration and progression of Parkinson’s disease. Am J Neurodegenerative Diseases 2012;1:217.
Rajendran L, Honsho M, Zahn TR. Alzheimer’s disease β-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci 2006;103:11172-7.
Malm T, Loppi S, Kanninen KM. Exosomes in Alzheimer's disease. Neurochem Int 2016;97:193-9.
Costa Silva B, Aiello NM, Ocean AJ. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 2015;17:816-26.
Jarmalaviciutė A, Pivoriunas A. Exosomes as a potential novel therapeutic tool against neurodegenerative diseases. Pharmacol Res 2016;113:816-22.
Howitt J, Hill AF. Exosomes in the pathology of neurodegenerative diseases. J Biol Chem 2016;291:26589-97.
Lai CPK, Breakefield XO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Frontiers Physiol 2012;3:228.
Natasha G, Gundogan B, Tan A. Exosomes as immunotherapeutic nanoparticles. Clin Ther 2014;36:820-9.
Amoozgar Z, Goldberg MS. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy. Adv Drug Delivery Rev 2015;91:38-51.
Hamdy S, Haddadi A, Hung RW, Lavasanifar A. Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Adv Drug Delivery Rev 2011;63:943-55.
Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 2017;38:754-63.
Qi Y, Xu Q, Wang Y, Yan B, Ren Y, Chen Z. CO2-induced phase engineering: protocol for enhanced photoelectrocatalytic performance of 2D MoS2 nanosheets. ACS Nano 2016;10:2903-9.
Morales Kastresana A, Telford B, Musich TA. Labeling extracellular vesicles for nanoscale flow cytometry. Sci Rep 2017;7:1878.
Kamerkar S, LeBleu VS, Sugimoto H. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 2017;546:498-503.
Stremersch S, Vandenbroucke RE, Wonterghem EV, Hendrix A, DeSmedt SC, Raemdonck K. Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs. J Controlled Release 2016;232:51-61.
Sun DM, Zhuang XY, Xiang XY, Liu YL, Zhang SY, Liu CR. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 2010;1:606-14.
Tian YH, Li SP, Song J, TJ Ji, Zhu MT. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 2014;35:2383-90.
Yang TZ, P Martin P, Fogarty B, Brown A. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio Rerio. Pharm Res 2015;32:2003-14.
MJ Haney, NL Klyachko, YL Zhao, R Gupta, EG Plotnikova, ZJ He. Exosomes as drug delivery vehicles for Parkinson׳s disease therapy. J Controlled Release 2015;207:18-30.
Wahlgren J, Karlson TDL, Brisslert M, Sani FV, Telemo E, Sunnerhagen P. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 2012;40:130.
Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Communication Signaling 2013;88:1186-96.
Banizs AB, Huang T, Dryden K, Berr SS, Stone JR. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery. Int J Nanomed 2014;9:4223-30.